<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28325529</identifier>
<setSpec>1699-7980</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Pérez-Haro, M L</dc:author>
<dc:author>Tamargo-Diaz, E M</dc:author>
<dc:author>Fernandez-Gomez, J M</dc:author>
<dc:author>San Martín-Blanco, A</dc:author>
<dc:author>García-Rodríguez, J</dc:author>
<dc:author>Quintás-Blanco, A</dc:author>
<dc:author>González-Ruiz de L, C</dc:author>
<dc:author>Valles-Antuña, C</dc:author>
<dc:description xml:lang="en">OBJECTIVE To assess the efficacy of treatment with transcutaneous posterior tibial nerve stimulation (TPTNS) in patients with urge urinary incontinence, of neurogenic or nonneurogenic origin, refractory to first-line therapeutic options. MATERIAL AND METHODS We included 65 patients with urge urinary incontinence refractory to medical treatment. A case history review, a urodynamic study and a somatosensory evoked potentials (SEP) study were conducted before the TPTNS, studying the functional urological condition by means of a voiding diary. The treatment consisted of 10 weekly sessions of TPTNS lasting 30minutes. RESULTS Some 57.7% of the patients showed abnormal tibial SEPs, and 42% showed abnormal pudendal SEPs. A statistically significant symptomatic improvement was observed in all clinical parameters after treatment with TPTNS, and 66% of the patients showed an overall improvement, regardless of sex, the presence of underlying neurological disorders, detrusor hyperactivity in the urodynamic study or SEP disorders. There were no adverse effects during the treatment. CONCLUSIONS TPTNS is an effective and well tolerated treatment in patients with urge incontinence refractory to first-line therapies and should be offered early in the treatment strategy. New studies are needed to identify the optimal parameters of stimulation, the most effective treatment protocols and long-term efficacy, as well as its applicability to patients with a neurogenic substrate.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Vejiga hiperactiva</dc:subject>
<dc:subject>Nervio tibial</dc:subject>
<dc:subject>Tibial nerve</dc:subject>
<dc:subject>Estimulación transcutánea</dc:subject>
<dc:subject>Peripheral neuromodulation</dc:subject>
<dc:subject>Incontinencia urinaria por urgencia</dc:subject>
<dc:subject>Overactive bladder</dc:subject>
<dc:subject>Urge incontinence</dc:subject>
<dc:subject>Neuromodulación periférica</dc:subject>
<dc:subject>Transcutaneous stimulation</dc:subject>
<dc:date>2017 Sep </dc:date>
<dc:title xml:lang="es">Estimulación transcutánea del nervio tibial posterior en el tratamiento de la incontinencia urinaria de urgencia refractaria, de origen idiopático y neurógenico.</dc:title>
<dc:title xml:lang="en">Transcutaneous stimulation of the posterior tibial nerve for treating refractory urge incontinence of idiopathic and neurogenic origin.</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
